Changeflow GovPing Healthcare & Life Sciences Culture Method for Organoids
Routine Notice Added Final

Culture Method for Organoids

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

Koninklijke Nederlandse Akademie Van Wetenschappen filed patent application US20260109944A1 on April 23, 2026, covering improved culture methods for expanding epithelial stem cells and obtaining organoids, along with related culture media and uses. The application names Meritxell Huch Ortega, Johannes Carolus Clevers, and Sylvia Fernandez Boj as inventors, with a priority filing date of April 24, 2025. Patent examiners and applicants will monitor prosecution of this application through the USPTO examination process.

“The invention relates to improved culture methods for expanding epithelial stem cells and obtaining organoids, to culture media involved in said methods, and to uses of said organoids.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 227 changes logged to date.

What changed

The USPTO published patent application US20260109944A1, filed by the Koninklijke Nederlandse Akademie Van Wetenschappen (Dutch Academy of Sciences), covering culture methods for expanding epithelial stem cells and generating organoids, including the culture media compositions and applications of the resulting organoids. This represents a published patent application, not an issued patent, and does not yet grant enforceable IP rights.

Pharmaceutical companies and healthcare providers engaged in organoid research or regenerative medicine should monitor this application's prosecution status, as a granted patent could affect research licensing or product development pathways in this space. Research institutions and biotech firms working with stem cell culture or organoid models may want to evaluate potential freedom-to-operate implications.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Culture Method for Organoids

Application US20260109944A1 Kind: A1 Apr 23, 2026

Assignee

Koninklijke Nederlandse Akademie Van Wetenschappen

Inventors

Meritxell Huch Ortega, Johannes Carolus Clevers, Sylvia Fernandez Boj

Abstract

The invention relates to improved culture methods for expanding epithelial stem cells and obtaining organoids, to culture media involved in said methods, and to uses of said organoids.

CPC Classifications

C12N 5/0602 A61K 35/39 A61K 35/407 C12N 5/067 C12N 5/0671 C12N 5/0676 C12N 5/0677 C12N 2501/01 C12N 2501/11 C12N 2501/115 C12N 2501/119 C12N 2501/12 C12N 2501/15 C12N 2501/155 C12N 2501/19 C12N 2501/30 C12N 2501/345 C12N 2501/415 C12N 2501/42 C12N 2501/999 C12N 2503/02 Y02A 50/30

Filing Date

2025-04-24

Application No.

19188730

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260109944A1

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254.1 Biotechnology
Activity scope
Patent application Stem cell research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!